203 related articles for article (PubMed ID: 22527432)
1. Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.
Martiniuk F; Giovinazzo J; Tan AU; Shahidullah R; Haslett P; Kaplan G; Levis WR
J Drugs Dermatol; 2012 May; 11(5):626-30. PubMed ID: 22527432
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.
Haslett PA; Roche P; Butlin CR; Macdonald M; Shrestha N; Manandhar R; Lemaster J; Hawksworth R; Shah M; Lubinsky AS; Albert M; Worley J; Kaplan G
J Infect Dis; 2005 Dec; 192(12):2045-53. PubMed ID: 16288366
[TBL] [Abstract][Full Text] [Related]
4. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction.
Rosa TLSA; Leal-Calvo T; Tavares IF; Mendes MA; Dias AA; Piauy MHDS; Barboza MFDS; Kapuscinski M; Costa FDMR; Marques MAM; Belone AFF; Sales AM; Hacker MA; Moreira MBP; Belisle JT; Moraes MO; Pessolani MCV; Schmitz V
Front Immunol; 2024; 15():1366125. PubMed ID: 38715615
[TBL] [Abstract][Full Text] [Related]
5. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
6. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
9. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
[TBL] [Abstract][Full Text] [Related]
10. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
11. The effect of antigen presenting cells on the cytokine profiles of stable and reactional lepromatous leprosy patients.
Nath I; Vemuri N; Reddi AL; Jain S; Brooks P; Colston MJ; Misra RS; Ramesh V
Immunol Lett; 2000 Dec; 75(1):69-76. PubMed ID: 11163869
[TBL] [Abstract][Full Text] [Related]
12. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I
Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
[TBL] [Abstract][Full Text] [Related]
13. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
14. Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions.
Sreenivasan P; Misra RS; Wilfred D; Nath I
Immunology; 1998 Dec; 95(4):529-36. PubMed ID: 9893041
[TBL] [Abstract][Full Text] [Related]
15. Erythema Nodosum Leprosum Neutrophil Subset Expressing IL-10R1 Transmigrates into Skin Lesions and Responds to IL-10.
Pacheco FS; Prata RBDS; Brandão SS; Ferreira H; Rodrigues TF; Brandão Dos Santos J; da Silva CO; Tavares IF; Mendes MA; Rodrigues ACDP; Machado AM; Nery JADC; Amadeu TP; Moraes MO; Sarno EN; Schmitz V
Immunohorizons; 2020 Feb; 4(2):47-56. PubMed ID: 32034084
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
[TBL] [Abstract][Full Text] [Related]
18. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
19. Thalidomide levels in patients with erythema nodosum leprosum.
Vieira JL; Valente Mdo S
Ther Drug Monit; 2009 Oct; 31(5):602-3. PubMed ID: 19704404
[TBL] [Abstract][Full Text] [Related]
20. In vitro thalidomide does not interfere with the activation of complement by M. leprae.
Shannon EJ; Sandoval FG; Morales MJ
J Drugs Dermatol; 2011 Mar; 10(3):274-8. PubMed ID: 21369644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
